PV pharm branch, vendor, cage 0U9U0
Ended Awarded Last action
- Contract number
- SPE2D826FA2WB
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $10,448
Award facts
- Contract value 100% obligated
- $10,447.93 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, issued on December 22, 2025, awards AmerisourceBergen Drug Corp $10,447.93 for pharmaceutical and medical supply deliveries under a firm fixed price arrangement. The contract represents a child order under the company's larger Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award is non-set-aside and was competitively awarded, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is funded by the Defense Logistics Agency's Medical Supply Chain organization, which procures critical pharmaceutical products and medical supplies to support military healthcare systems.
As a major pharmaceutical distributor, AmerisourceBergen Drug Corp supplies an extensive portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support Department of Defense and veteran healthcare requirements. The company's demonstrated capability to fulfill diverse federal medical procurement needs through open competition, combined with its substantial prime indefinite delivery contract vehicle, positions it as a key vendor within the federal pharmaceutical supply chain. The Defense Logistics Agency's planned Pharmaceutical Prime Vendor Global Program Generation V initiative, which may involve multiple regional awards, reflects the strategic importance of maintaining robust relationships with capable pharmaceutical distributors like AmerisourceBergen Drug Corp to ensure continuous global medical supply support for military personnel and beneficiaries.
Quick answers
Who was awarded contract SPE2D826FA2WB?
SPE2D826FA2WB was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on December 22, 2025.
How much is contract SPE2D826FA2WB worth?
The government has obligated $10,448 on SPE2D826FA2WB.
Is contract SPE2D826FA2WB an order under another contract?
Yes. SPE2D826FA2WB is a delivery order under SPE2DX22D0049, an indefinite delivery contract.
Was contract SPE2D826FA2WB competed?
The extent of competition for SPE2D826FA2WB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award